Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Lymphokine and Cytokine Research|April 1, 1992
Lymphokine-activated effector cells: modulation of activity by cytokinesS Mehta, P Flanagan, D Blackinton, et al.Annals of Surgery|June 24, 1998
Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancerH Wanebo, M Coburn, D Teates, et al.Annals of Surgery|October 1, 1978
Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancerJ H Wanebo, M Stearns, M K SchwartzMelanoma Research|May 1, 1992
Induction of interleukin-2, natural killer cell activity and anti-melanoma antibodies resulting from immunization of mice with formalinized extracellular antigens (FECA) of murine melanomaD Shrayer, J Koness, A Maizel, et al.Melanoma Research|May 1, 1992
Basic fibroblast growth factor production and growth factor receptors as potential targets for melanoma therapyJ Kato, H Wanebo, P Calabresi, et al.Cancer|May 1, 1981
Defective suppressor cell activity in cancer patients: a defect in immune regulationG W Hubbard, H Wanebo, M Fukuda, et al.The Journal of Clinical Investigation|June 1, 1977
Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patientsH Teshima, H Wanebo, C Pinsky, et al.American Journal of Surgery|October 1, 1991
Augmentation of the lymphokine-activated killer cell response in head and neck cancer patients by combination interleukin-2 and interferon-alphaH Wanebo, D Blackinton, T Weigel, et al.Cancer|December 1, 1981
Dose local x-irradiation of a tumor increase the incidence of metastases?D Baker, D Elkon, M L Lim, et al.Cancer Immunology, Immunotherapy : CII|May 1, 1995
Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccineD Shrayer, H Bogaars, V J Hearing, et al.Pageof 4